Scientific Letter

Low-level viraemia despite emergence of dolutegravir-resistant variants

Johannes C. Botha, Kim Steegen, Mariam Edoo, Jeremy Nel, Gert U. van Zyl
Southern African Journal of HIV Medicine | Vol 23, No 1 | a1398 | DOI: https://doi.org/10.4102/sajhivmed.v23i1.1398 | © 2022 Johannes C. Botha, Kim Steegen, Mariam Edoo, Jeremy Nel, Gert U. van Zyl | This work is licensed under CC Attribution 4.0
Submitted: 03 May 2022 | Published: 30 September 2022

About the author(s)

Johannes C. Botha, Department of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
Kim Steegen, Department of Molecular Medicine and Haematology, Faculty of Health Sciences, National Health Laboratory Service, Johannesburg, South Africa; and, Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Mariam Edoo, Department of Medicine, Helen Joseph Hospital, Johannesburg, South Africa
Jeremy Nel, Department of Medicine, Helen Joseph Hospital, Johannesburg, South Africa; and, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa
Gert U. van Zyl, Department of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; and, Department of Molecular Medicine, National Health Laboratory Service, Cape Town, South Africa

Abstract

No abstract available.


Keywords

HIV; Dolutegravir; slow viremia decline; second line; INSTI naïve; drug resistance

Metrics

Total abstract views: 2194
Total article views: 2024

 

Crossref Citations

1. Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review
Kaiming Tao, Soo-Yon Rhee, Carolyn Chu, Ava Avalos, Amrit K. Ahluwalia, Ravindra K. Gupta, Michael R. Jordan, Robert W. Shafer
Viruses  vol: 15  issue: 9  first page: 1932  year: 2023  
doi: 10.3390/v15091932